Heparin Cofactor II (SERPIND1) Rabbit Polyclonal Antibody TA313999 from OriGene Technologies | Biocompare.com

Supplier Images

Heparin Cofactor II (SERPIND1) Rabbit Polyclonal Antibody

Be the first to write a review!

Citations:

Supplier Page from
OriGene Technologies for
Heparin Cofactor II (SERPIND1) Rabbit Polyclonal Antibody

The Heparin Cofactor II (SERPIND1) Rabbit Polyclonal Antibody from OriGene Technologies is a Rabbit Polyclonal antibody. This antibody recognizes Human, Mouse, and Rat antigen. The Heparin Cofactor II (SERPIND1) Rabbit Polyclonal Antibody has been validated for the following applications: Immunocytochemistry, Immunofluorescence, and Immunohistochemistry.

Description

Rabbit polyclonal Heparin Cofactor II antibody

Product Specs
ItemHeparin Cofactor II (SERPIND1) Rabbit Polyclonal Antibody
CompanyOriGene Technologies
Price Pricing Info Supplier Page View Company Product Page
Catalog NumberTA313999
Quantity100 µl
ApplicationsIF, IHC
Concentrationlot specific
Conjugate/TagUnconjugated
PurityThe antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen
ReactivityHuman, Mouse, Rat
TargetSERPIND1
IsotypeIgG
HostRabbit
Antibody TypePrimary Antibodies
ImmunogenThe antiserum was produced against synthesized peptide derived from internal of human Heparin Cofactor II
NCBI Full Gene Nameserpin family D member 1
NCBI Gene AliasesHC2, D22S673, HCII, THPH10, HCF2, LS2, HLS2
ClonalityPolyclonal
TypePrimary Antibodies
FormatPhosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol

Specifications/Features

Purification: The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.

Add to Compare List

OriGene Technologies

OriGene Technologies

9620 Medical Center Drive # 200

Rockville, Maryland 20850

United States

Phone: 1-888-267-4436 (U.S. only) / 301-340-3188
301-340-9254

Company Profile

Website: http://www.origene.com

(1) Development and external validation of a composite immune-clinical prognostic model associated with EGFR mutation in East-Asian patients with lung adenocarcinomaTherapeutic advances in medical oncologyJanuary 1, 2021Liu C, Zheng S, Wang S, Wang X, Feng X, Sun N, He J.serpin family D member 1 (SERPIND1) assay (anti-human SERPIND1 rabbit recombinant polyclonal antibody, TA313999; OriGene, USA). All IHC slides were evaluated by two experienced pathologists blinded to clinical characteristics

Be the First to Write a Review!